Filing a China Drug Master File (DMF) involves navigating complex regulatory requirements, language barriers, and ensuring compliance with Chinese standards. Companies face challenges in document preparation, understanding local regulations, and maintaining confidentiality. Additionally, frequent regulatory updates and the need for local representation can complicate the submission process, demanding meticulous attention to detail.
